E-cigarette Usage in UK Reaches Record High Levels

Aug.12.2024
E-cigarette Usage in UK Reaches Record High Levels
The e-cigarette use among UK adults has reached a record high, with 11% using them, totaling 5.6 million people.

According to a report from the Shropshire Star on August 12th, the use of e-cigarettes among adults in the UK has reached a record high. The latest data shows that 11% of UK adults use e-cigarettes, equating to 5.6 million people.


According to data from Action on Smoking and Health (ASH) in the UK, approximately 53% of e-cigarette users, which is equivalent to 3 million people, were previously traditional cigarette smokers. Currently, the proportion of people who use both traditional cigarettes and e-cigarettes has increased from 17% in 2021 to 32% in 2024, equivalent to 2.2 million people.


Ash's deputy chief executive Hazel Cheeseman said:


Smoking remains the biggest preventable killer in the UK, and e-cigarettes are one of the important tools to help smokers quit in order to achieve a smoke-free nation for both current and future generations.


Professor Sanjay Agrawal, Special Advisor on Tobacco Issues at the Royal College of Physicians and Consultant in Respiratory and Intensive Care Medicine at the University Hospitals of Leicester NHS Trust, added:


In the past few years, almost all of the patients I have encountered who have successfully quit smoking have done so by using e-cigarettes, without which they may have not been able to quit. E-cigarettes have been used by quit smoking services and the NHS to support smokers, but we can still more widely use this tool to help millions of people who are still smoking to quit.


According to reports, in July of this year, the Labour government restarted its plan to introduce the Tobacco and E-Cigarette Bill, which could gradually raise the age limit for purchasing tobacco and prevent anyone born after January 1, 2009 from legally purchasing tobacco. The bill could also impose restrictions on the flavors, packaging, and display of e-cigarettes.


Ms. Chisman emphasized that the proposed e-cigarette legislation should focus on preventing children from using e-cigarettes, rather than adults who are looking to quit smoking. She added:


In recent years, millions of people have successfully quit smoking by using e-cigarettes, extending their healthy lifespan and boosting national productivity. There is an urgent need for stricter regulations on e-cigarettes, but it is important that these regulations target teenage e-cigarette use specifically, without hindering their use as a smoking cessation aid.


Henry Gregg, Director of External Affairs for the British Lung Foundation, said:


Quitting smoking can be very difficult, and it is great to see that many smokers are finding e-cigarettes to be a very effective tool for quitting. However, in order to help more smokers quit, the government must increase investment in local smoking cessation services. In recent years, these services have faced significant cuts, but they have excelled in supporting people to quit smoking permanently and address the deadly consequences of smoking.


According to a survey, half of smokers believe that e-cigarettes are as harmful as traditional cigarettes, and 60% of non-e-cigarette users who smoke also share the same view.


A spokesperson for the UK Department of Health and Social Care stated:


Although e-cigarettes can be an effective tool for quitting smoking, health advice clearly states that non-smoking children and adults should never use e-cigarettes. The upcoming Tobacco and E-Cigarette Act will protect future generations from the harm of tobacco and nicotine, saving thousands of lives. By establishing a healthier society, it will also contribute to building a healthier economy.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | JNR Launches Shisha Hookah 70K E-Hookah With 60ml E-Liquid and 0.6% Nicotine
Product | JNR Launches Shisha Hookah 70K E-Hookah With 60ml E-Liquid and 0.6% Nicotine
JNR has introduced the Shisha Hookah 70K, a high-capacity rechargeable disposable vape designed around a hookah-inspired experience. The device comes prefilled with 60ml of e-liquid at 6mg/ml (0.6%) nicotine strength, alongside a 1,000mAh rechargeable battery and a 0.38Ω single mesh coil. It also features adjustable airflow and battery and e-liquid level displays. JNR claims the device can deliver up to 70,000 puffs and offers more than 20 flavors. Retail listings for the product have appeared in markets including Tunisia.
Market
Aug.24 by 2Firsts Perspectives
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
The U.S. Food and Drug Administration has revised the rules under Import Alert 98-07 to incorporate its May 2026 enforcement-priority policy for certain electronic nicotine delivery systems marketed without premarket authorization. The alert continues to allow detention without physical examination, or DWPE, for ENDS lacking required marketing authorization, while directing field divisions to apply the May risk-based framework. When necessary, detention or refusal decisions must also undergo review by the FDA's Center for Tobacco Products. Products including PACHA and Vuse Pro have already emerged as industry examples of the May policy, although enforcement discretion does not constitute FDA marketing authorization.
News
Sep.28 by 2Firsts Perspectives
FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
The FDA has authorized four additional on! nicotine pouches, bringing the U.S. total to 30. The decision marks another outcome of the agency’s nicotine pouch review pilot, whose communication and review practices are now being applied more broadly across the category. It also extends Helix’s authorized portfolio from on! PLUS to the earlier on! line. Yet all FDA-authorized nicotine pouches still come from subsidiaries of PMI or Altria, underscoring how concentrated U.S. regulatory access remains.
Aug.05
Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Holdings said in its latest shareholder letter that it is moving to commercialize PACHA products and monetize its PMTA assets as the FDA changes enforcement priorities for unauthorized ENDS products. Thirty PACHA SKUs were previously tentatively identified for a proposed public list of products that the FDA generally does not intend to prioritize for enforcement. Charlie’s is also preparing test-market sales of age-gated flavored disposables and says it currently holds 678 PMTA-related product assets while seeking additional strategic transactions and partnerships.
Sep.11
China Tobacco Regulator Deputy Head Visits Laos as Both Sides Strengthen Cooperation on Illegal Tobacco Trade
China Tobacco Regulator Deputy Head Visits Laos as Both Sides Strengthen Cooperation on Illegal Tobacco Trade
China’s official Xinhua News Agency reported that Liu Sanjiang, deputy head and Party group member of China’s tobacco regulator, led a delegation to Laos from July 31 to Aug. 2, 2026, for discussions with Lao authorities on combating cross-border illegal tobacco trade. The two sides discussed areas including law enforcement cooperation, information sharing and efforts to address tobacco-related illegal activities such as counterfeiting and smuggling. The visit highlights cooperation between Chinese and Lao authorities on illicit tobacco control.
News
Aug.05
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia's Therapeutic Goods Administration published a final decision on September 25 to classify 6-methylnicotine as a Schedule 9 prohibited substance under the Poisons Standard, effective October 1, 2026. TGA said the chemical has been reported in e-cigarette liquids sold in Australia and marketed as nicotine-free or nicotine alternatives, while evidence also indicates its use in preparations such as oral pouches. The government originally proposed a Schedule 7 classification but ultimately adopted the stricter Schedule 9 designation, citing acute toxicity, dependence risk, use in unapproved consumer products and misleading marketing.
News
Sep.29 by 2Firsts Perspectives